Heparin-binding haemagglutinin-induced interferon-gamma secretion as a diagnostic tool for latent tuberculosis in low TB-burden country.
Jean‐Michel Hougardy(Erasmus Hospital), Françoise Mascart(Université Libre de Bruxelles), Virginie Versheure, Sammy Place(Epicura), Anne‐Sophie Debrie(Inserm), T. Mark Doherty(Statens Serum Institut), Jean‐Paul Van Vooren(Université Libre de Bruxelles), Camille Locht(Centre National de la Recherche Scientifique), Kinda Schepers(Délégation Paris 5), Annie Drowart(Centre Hospitalier Universitaire Brugmann)
Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles)
February 1, 2007
Cited by 0
Related Papers
Clinical and epidemiological characteristics of 1420 European patients with mild‐to‐moderate coronavirus disease 2019
|Journal of Internal Medicine|2020|847
Immunogenicity and protective efficacy of a tuberculosis DNA vaccine
|Nature Medicine|1996|632
The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination
|Nature|2001|464
Deep Dermatophytosis and Inherited CARD9 Deficiency
|New England Journal of Medicine|2013|403
Activation of the Pro-drug Ethionamide Is Regulated in Mycobacteria
|Journal of Biological Chemistry|2000|299